BioShares Biotechnology Technical Analysis 
BioShares Biotechnology Clinical Trials  USA Etf  USD 29.97 0.98 3.16% 
BioShares Biotechnology Clinical Trials shows Downside Deviation of 1.39, Risk Adjusted Performance of 0.1634 and Mean Deviation of 1.17. BioShares Biotechnology technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the entity future prices. In plain English you can use this information to find out if the entity will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for BioShares Biotechnology Clinical Trials which can be compared to its rivals. Please confirm BioShares Biotechnology Maximum Drawdown, Semi Variance and the relationship between Jensen Alpha and Potential Upside to decide if BioShares Biotechnology is priced correctly providing market reflects its regular price of 29.97 per share.
Time Horizon  30 Days Login to change 
BioShares Biotechnology Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioShares Biotechnology volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
BioShares Biotechnology Trend Analysis
Use this graph to draw trend lines for BioShares Biotechnology Clinical Trials. You can use it to identify possible trend reversals for BioShares Biotechnology as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual BioShares Biotechnology price movement. To start drawing, click on the pencil icon on topright. To remove the trend, use eraser icon.BioShares Biotechnology Best Fit Change Line
The following chart estimates an ordinary least squares regression model for BioShares Biotechnology Clinical Trials applied against its price change over selected period. The best fit line has a slop of 0.17 % which may imply that BioShares Biotechnology Clinical Trials will maintain its good market sentiment and make money for investors. It has 34 observation points and a regression sum of squares at 24.16, which is the sum of squared deviations for the predicted BioShares Biotechnology price change compared to its average price change.Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on meanvariance optimization algorithm 
Hide View All Next  Launch Watchlist Optimization 
Mean Deviation  ...

Technical Drivers
BioShares Biotechnology January 16, 2018 Technical Indicators
Cycle Indicators  
Math Operators  
Math Transform  
Momentum Indicators  
Overlap Studies  
Pattern Recognition  
Price Transform  
Statistic Functions  
Volatility Indicators  
Volume Indicators 
Risk Adjusted Performance  0.1634  
Market Risk Adjusted Performance  0.6684  
Mean Deviation  1.17  
Semi Deviation  0.6236  
Downside Deviation  1.39  
Coefficient Of Variation  248.92  
Standard Deviation  1.47  
Variance  2.17  
Information Ratio  0.2419  
Jensen Alpha  0.3827  
Total Risk Alpha  (0.27)  
Sortino Ratio  0.2568  
Treynor Ratio  0.6584  
Maximum Drawdown  5.11  
Value At Risk  (1.84)  
Potential Upside  2.79  
Downside Variance  1.93  
Semi Variance  0.3888  
Expected Short fall  (1.43)  
Skewness  (0.1)  
Kurtosis  (0.65) 
One Year Return
BioShares Biotechnology One Year Return
Based on recorded statements BioShares Biotechnology Clinical Trials has One Year Return of 56%. This is 352.42% higher than that of the Bio Shares family, and 352.6% higher than that of Health category, The One Year Return for all etfs is 4588.0% lower than the firm.
Year Return 
Fundamentals Correlations
Analyze BioShares Biotechnology Fundamentals Trends